OMB completed its initial regulatory review of HHS' prerule titled "340B Drug Pricing Program Manufacturer Rebate Models."

White House Completes Initial Regulatory Review of HHS’ New 340B Rebate Proposal

February 12, 2026 William Newton, Associate Editor/Senior Writer 340B Report Views

The White House’s Office of Management and Budget (OMB) has completed its initial regulatory review of the federal government’s new [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!